Medicines Distribution Consent




NEW ZEALAND GAZETTE, No. 118

1 NOVEMBER 2007

Health

Medicines Act 1981

Consent to the Distribution of Changed Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Humira Pen
Active Ingredient: Adalimumab 50mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturers: Abbott Laboratories Limited, Queenborough, Kent, United Kingdom
Vetter Pharma-Fertigung GmbH & Co Kg, Ravensburg, Germany

Product: Humira
Active Ingredient: Adalimumab 50mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturers: Vetter Pharma-Fertigung GmbH & Co Kg, Ravensburg, Germany
Wasserburger Arzneimittelwerk GmbH, Wasserburg, Germany

Product: Pegatron Combination Therapy (Combination Product)
Component: PEG-Intron Redipen
Active Ingredient: Peginterferon alfa-2b 100µg
Dosage Form: Powder for injection
Diluent
Manufacturer: Schering-Plough Limited (Biotechnology Plant), Singapore
Component: Rebetol Capsule
Active Ingredient: Ribavirin 200mg
Manufacturer: Schering-Plough Products Inc, Pridco Industrial Park, Las Piedras, Puerto Rico
New Zealand Sponsor: Schering-Plough, a division of Schering-Plough Animal Health Limited

Product: Pegatron Combination Therapy (Combination Product)
Component: PEG-Intron Redipen
Active Ingredient: Peginterferon alfa-2b 120µg
Dosage Form: Powder for injection
Diluent
Manufacturer: Schering-Plough Limited (Biotechnology Plant), Singapore
Component: Rebetol Capsule
Active Ingredient: Ribavirin 200mg
Manufacturer: Schering-Plough Products Inc, Pridco Industrial Park, Las Piedras, Puerto Rico
New Zealand Sponsor: Schering-Plough, a division of Schering-Plough Animal Health Limited

Product: Pegatron Combination Therapy (Combination Product)
Component: PEG-Intron Redipen
Active Ingredient: Peginterferon alfa-2b 150µg
Dosage Form: Powder for injection
Diluent
Manufacturer: Schering-Plough Limited (Biotechnology Plant), Singapore
Component: Rebetol Capsule
Active Ingredient: Ribavirin 200mg
Manufacturer: Schering-Plough Products Inc, Pridco Industrial Park, Las Piedras, Puerto Rico
New Zealand Sponsor: Schering-Plough, a division of Schering-Plough Animal Health Limited



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2007, No 118


Gazette.govt.nz PDF NZ Gazette 2007, No 118





✨ LLM interpretation of page content

🏥 Consent to the Distribution of Changed Medicines

🏥 Health & Social Welfare
Medicines Act 1981, Distribution Consent, Changed Medicines, Humira, Pegatron Combination Therapy
  • Minister of Health